@article{26fcae70532741a6a1fd3469befe6247,
title = "Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study",
keywords = "beta 2 microglobulin, hemoglobin, ibrutinib, lactate dehydrogenase, adenine, immunological antineoplastic agent, piperidine derivative, protein kinase inhibitor, adult, age, aged, Article, biological functions, blood toxicity, cancer immunotherapy, cancer mortality, cancer prognosis, cancer staging, chromosome 17p, chromosome deletion, chronic lymphatic leukemia, clinical feature, cohort analysis, controlled study, cross validation, disease association, drug withdrawal, female, follow up, gender, gene, gene mutation, hemoglobin blood level, high risk patient, human, IGHV gene, intermediate risk patient, laboratory test, leukemia relapse, low risk patient, major clinical study, male, overall survival, prediction, priority journal, risk assessment, risk factor, salvage therapy, survival analysis, treatment duration, molecularly targeted therapy, mortality, prognosis, treatment outcome, Adenine, Antineoplastic Agents, Immunological, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Molecular Targeted Therapy, Piperidines, Prognosis, Protein Kinase Inhibitors, Treatment Outcome",
author = "M. Gentile and F. Morabito and {Del Poeta}, G. and F.R. Mauro and G. Reda and P. Sportoletti and L. Laurenti and M. Coscia and Y. Herishanu and A.G. Recchia and M. Varettoni and R. Murru and A. Chiarenza and A. Condoluci and R. Moia and D. Pietrasanta and G. Loseto and U. Consoli and I. Scortechini and F.M. Rossi and A. Zucchetto and V. Fraticelli and E. Vigna and C. Botta and G. Tripepi and G.D. Arrigo and A. Rago and I. Angeletti and A. Biagi and {Del Giudice}, I. and R. Bomben and G.M. Rigolin and D. Rossi and {Di Raimondo}, F. and G. Gaidano and A. Polliack and A. Cuneo and R. Fo{\`a} and V. Gattei",
note = "Cited By :15 Export Date: 2 February 2022 CODEN: LEUKE Correspondence Address: Gentile, M.; Hematology Unit AO of CosenzaItaly; email: massim.gentile@tiscali.it Correspondence Address: Gattei, V.; Clinical and Experimental Onco-Hematology Unit, Italy; email: vgattei@cro.it",
year = "2021",
doi = "10.1038/s41375-020-0833-x",
language = "English",
volume = "35",
pages = "235--238",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "1",
}